Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Issue of Equity

3 Sep 2008 07:00

RNS Number : 5963C
Imaginatik PLC
03 September 2008
Β 

ο»Ώ

Imaginatik Plc ("Imaginatik" or the "Company")

Issue of Equity

3 September 2008

Imaginatik plc (AIM: IMGK), a leading provider of collaborative innovation and problem-solving software and processes,Β is pleased to announce that it has raised approximately Β£222,000 before expenses by way of a conditional placing of 5,550,000 new Ordinary Shares of 0.0625p each (the "Placing Shares") at 4p per Placing Share from institutional placees.Β 

The proceeds of the Placing will be invested in Imaginatik's sales operation in theΒ UKΒ and US in order to increase follow-through sales to the Company's major Fortune 500 and FTSE 100 clients.

Application for admission of the Placing Shares ("Admission") has been made and is expected to occur on 9 September 2008. The Placing is conditional, amongst other things, on Admission becoming effective.

Following Admission, the Company will have 131,377,799 Ordinary Shares in issue. The Placing Shares represent approximately 4.22 per cent. of the enlarged issued share capital of the Company immediately following Admission and each of the Placing Shares will be credited as fully paid and free from all liens, equities, charges, encumbrances and other interests and will, when issued, rank in full for all dividends and distributions thereafter declared, made or paid after Admission and otherwise rank pari passu in all respects with, and carry the same voting and dividend rights as, the existing Ordinary Shares.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company.Β 

The number of Placing Shares does not exceed the number of Ordinary Shares which the directors of Imaginatik are currently able to allot and which can be allotted free from statutory rights of pre-emption under existing authorities from shareholders passed at the annual general meeting of the Company which was held on 10 July 2008.

The Placing is to be carried out on behalf of the Company by WH Ireland Limited ("WHI") on the terms of a placing agreement dated 2 September 2008 and which contains warranties and indemnities from the Company in relation to Admission, the Placing and certain aspects of the Company's financial and trading position. Under this agreement, WHI has agreed to act as agent of the Company to use its reasonable endeavours to procure subscribers for the Placing Shares. The Placing is not being underwritten.Β 

Mark Turrell, Chief Executive of Imaginatik, commented: "Following an improved start to the current financial year we felt the time was right to raise additional funds in order to capitalise on the current strong growth in the innovation and problem-solving market. Having achieved a market leading position, with an extensive blue-chip client base and award-winning software, this timely funding injection from our investors will enable an acceleration of our international growth plans creating additional long-term shareholder value."

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

WH IrelandΒ Limited

Tel: 0121 265 6330

Tim Cofman / Katy Birkin

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Mike Smith

About Imaginatik

Imaginatik is the leading provider of innovation and collaborative problem solving software and process to the world's leading companies. More than 100 clients rely on Imaginatik's software, consulting and research to enable their best-of-breed innovation activities.

Named as a World Economic Forum Technology Pioneer for 2008 and a finalist for the IBM Lotus Awards 2008 in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings, process improvements and increased product pipeline. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as theΒ LondonΒ BusinessΒ SchoolΒ and the Cass School of Business,Β London, as well as leading practitioners of corporate innovation.

For further information please visitΒ www.imaginatik.com


This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IOEEAXNAELSPEFE
Date   Source Headline
25th Jan 201211:30 amRNSHolding(s) in Company
23rd Jan 20127:01 amRNSContract Renewals worth £1.1m
3rd Jan 20127:00 amRNSDirectorate Change
22nd Dec 20117:00 amRNSContract extension
14th Dec 20117:00 amRNSLitigation Update
12th Dec 20117:00 amRNSContract Win
28th Nov 20117:00 amRNSHalf Yearly Report
28th Oct 20112:13 pmRNSChange of Adviser
28th Oct 201110:02 amRNSHolding(s) in Company
27th Oct 201110:45 amRNSHolding(s) in Company
13th Oct 20117:00 amRNSContract Extension
3rd Oct 201112:28 pmRNSDirectorate Change
26th Sep 20115:12 pmRNSResult of AGM
15th Sep 201110:24 amRNSHolding(s) in Company
2nd Sep 20113:25 pmRNSNotice of AGM
31st Aug 201111:46 amRNSHolding(s) in Company
26th Aug 20113:30 pmRNSResult of Open Offer and General Meeting
4th Aug 20119:32 amRNSPosting of Circular
2nd Aug 20117:15 amRNSProposed Placing, Subscription and Open Offer
2nd Aug 20117:00 amRNSFinal Results
29th Jul 201112:10 pmRNSNotice of Results
26th Apr 20117:00 amRNSIssue of Equity
14th Apr 20117:00 amRNSContract with the World Bank
1st Mar 20117:00 amRNSContract Wins and Trading Update
25th Jan 201111:22 amRNSWithdrawal of requisition of General Meeting
12th Jan 201111:01 amRNSHolding(s) in Company
11th Jan 20115:26 pmRNSIssue of Equity
22nd Dec 201012:24 pmRNSResult of General Meeting
22nd Dec 20107:00 amRNSFurther Requisition of General Meeting
16th Dec 20107:00 amRNSHalf Yearly Report
1st Dec 201010:08 amRNSNotice of General Meeting
19th Nov 20107:00 amRNSBoard Appointment
15th Nov 20103:28 pmRNSRequisition of General Meeting
11th Oct 20107:00 amRNSContract Extension with Pfizer
4th Oct 201011:58 amRNSShare Option Schemes
29th Sep 201011:41 amRNSResult of AGM
29th Sep 20107:00 amRNSAGM Statement
10th Sep 20105:00 pmRNSHolding in Company
10th Sep 20103:36 pmRNSHolding(s) in Company
10th Sep 20107:00 amRNSPilot Project Established with NASA
9th Sep 201012:47 pmRNSHolding(s) in Company
6th Sep 20104:14 pmRNSIssue of Equity
24th Aug 20103:16 pmRNSResult of General Meeting
18th Aug 20101:23 pmRNSMarket Update
6th Aug 20106:28 pmRNSPosting of Circular
30th Jul 20104:41 pmRNSHolding(s) in Company
27th Jul 20104:33 pmRNSPosting of Circular convening General Meeting
22nd Jul 201011:53 amRNSHolding(s) in Company
7th Jul 201011:04 amRNSSenior Management Team Appointments
23rd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.